{"id":"W2604623769","doi":"10.1016/j.jcjd.2017.08.242","title":"Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes","year":2017,"lang":"en","type":"review","venue":"Canadian Journal of Diabetes","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Type 2 diabetes; Semaglutide; Liraglutide; Lixisenatide; Incretin; Exenatide; Hypoglycemia; Drug class; Diabetes mellitus; Intensive care medicine; Endocrinology; Pharmacology; Drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007135253,0.0007722949,0.003433624,0.001011374,0.000424496,0.0003685396,0.0007117913,0.0003978094,0.000233364],"category_scores_gemma":[0.0007821023,0.000603117,0.001465746,0.0002634856,0.0002179001,0.0002718973,0.00004940055,0.0005256505,0.0001363328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009026047,"about_ca_system_score_gemma":0.003463322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006779419,"about_ca_topic_score_gemma":0.0007312942,"domain_scores_codex":[0.9966786,0.0001005108,0.001251357,0.0004646473,0.0002994513,0.00120546],"domain_scores_gemma":[0.9951727,0.0002988429,0.00179073,0.0008040994,0.0005351227,0.001398491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004819012,0.00007134032,0.001805595,0.01103439,0.003585381,0.00003759677,0.0000450144,3.238322e-7,0.000001990865,0.0001063405,0.08849044,0.8948168],"study_design_scores_gemma":[0.001048468,0.00113937,0.00005309568,0.02358566,0.006798094,0.000004291637,0.00002903626,0.000005983109,0.00001170951,0.00005429804,0.966773,0.0004969403],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001781161,0.9911262,0.000001127966,0.0004086141,0.002484217,0.001419591,0.0002763982,0.00002494939,0.00247778],"genre_scores_gemma":[0.000384054,0.9873406,0.00138848,0.0004547254,0.001766499,0.0001510526,0.0007947035,0.0002449219,0.00747499],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8943198,"threshold_uncertainty_score":0.999642,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05117790030075134,"score_gpt":0.3166139700665522,"score_spread":0.2654360697658008,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}